Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER GALLAGHER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1467430579
CMS profile
1059838
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$11,770.55

12 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $5,995.55 6
AstraZeneca Pharmaceuticals LP $4,050.00 3
Seagen Inc. $1,375.00 1
Athenex Pharmaceutical Division, LLC $350.00 2

Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER GALLAGHER

NPI 1467430579 · CMS profile ID 1059838

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467430579?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER GALLAGHER, NPI 1467430579, CMS profile ID 1059838. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467430579?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). CHRISTOPHER GALLAGHER, NPI 1467430579, CMS profile ID 1059838. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467430579?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
CHRISTOPHER GALLAGHER, NPI 1467430579, CMS profile ID 1059838, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–12 of 12 matching records. This page contains 12 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1467430579?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

12 matching records · $11,770.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 12 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–12 of 12.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $1,350.0012/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736029267 CMS
Athenex Pharmaceutical Division, LLC $175.0011/23/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844346105 CMS
Daiichi Sankyo Inc. $1,350.0011/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739476759 CMS
Daiichi Sankyo Inc. $1,350.0011/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739476761 CMS
Daiichi Sankyo Inc. $900.0011/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739478173 CMS
AstraZeneca Pharmaceuticals LP $1,350.0011/11/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735876313 CMS
Athenex Pharmaceutical Division, LLC $175.0011/04/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844346103 CMS
Daiichi Sankyo Inc. $1,350.0010/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739475477 CMS
AstraZeneca Pharmaceuticals LP $1,350.0010/05/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735933833 CMS
Seagen Inc. $1,375.0006/10/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732467029 CMS
Daiichi Sankyo Inc. $1,027.5005/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739477693 CMS
Daiichi Sankyo Inc. $18.0503/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739488209 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,596.91 4
PY2020 $11,770.55 12
PY2021 $14,659.83 14
PY2022 $32,572.39 26
PY2023 $30,914.33 25
PY2024 $12,283.14 19
PY2025 $3,812.19 26

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $134,677.68 26
PY2024 Principal investigator $192,960.63 22
PY2023 Recipient $109.20 1
PY2023 Principal investigator $287,719.82 33
PY2022 Principal investigator $223,087.49 47
PY2021 Recipient $2,220.00 4
PY2021 Principal investigator $184,110.05 25
PY2020 Principal investigator $291,681.40 53
PY2019 Principal investigator $138,556.60 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $611.18 12/31/2024 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE INC
A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candidates for PD 1/PD L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer No dispute reported 06/30/2026 1155802938
Principal investigator 1 AstraZeneca Pharmaceuticals LP $159.77 12/31/2024 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INST
A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candidates for PD 1/PD L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer No dispute reported 06/30/2026 1155804828
Principal investigator 1 GlaxoSmithKline, LLC. $2,000.00 11/15/2024 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE-BOSTON
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUA No dispute reported 06/30/2026 1127523008
Principal investigator 1 Daiichi Sankyo Inc. $39,870.00 10/18/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1145040554
Principal investigator 1 Daiichi Sankyo Inc. $5,100.00 10/11/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1145040564
Principal investigator 1 GlaxoSmithKline, LLC. $1,044.40 09/24/2024 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE-BOSTON
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUA No dispute reported 06/30/2026 1127523010
Principal investigator 1 Daiichi Sankyo Inc. $17,250.00 08/19/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1086064637
Principal investigator 1 Daiichi Sankyo Inc. $500.00 08/16/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064633
Principal investigator 1 Daiichi Sankyo Inc. $7,850.00 08/16/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064635
Principal investigator 1 Eli Lilly and Company $378.00 07/09/2024 Non-covered Recipient Entity
MEDSTAR WASHINGTON HOSPITAL CENTER
EMBER-4: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ADJUVANT IMLUNESTRANT VS STANDARD ADJUVANT ENDOCRINE THERAPY IN PATIENTS WHO HAVE PREVIOUSLY RECEIVED 2 TO 5 YEARS OF ADJUVANT ENDOCRINE THERAPY FOR ER+, HER2- EARLY BREAST CANCER WITH AN INCREASED RISK OF RECURRENCE No dispute reported 06/30/2026 1137361675
Principal investigator 1 Eli Lilly and Company $515.41 07/09/2024 Non-covered Recipient Entity
PRES AND DIR GEORGETOWN COLLEGE FOR GRGTWN UNIV
EMBER-4: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ADJUVANT IMLUNESTRANT VS STANDARD ADJUVANT ENDOCRINE THERAPY IN PATIENTS WHO HAVE PREVIOUSLY RECEIVED 2 TO 5 YEARS OF ADJUVANT ENDOCRINE THERAPY FOR ER+, HER2- EARLY BREAST CANCER WITH AN INCREASED RISK OF RECURRENCE No dispute reported 06/30/2026 1137365255
Principal investigator 1 Daiichi Sankyo Inc. $144.00 06/25/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064631
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,431.78 06/14/2024 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INST
A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candidates for PD 1/PD L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer No dispute reported 06/30/2026 1110835937
Principal investigator 1 Daiichi Sankyo Inc. $10,100.00 06/07/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064629
Principal investigator 1 Daiichi Sankyo Inc. $500.00 05/17/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1086064625
Principal investigator 1 Daiichi Sankyo Inc. $500.00 05/17/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064627
Principal investigator 1 AstraZeneca Pharmaceuticals LP $47,556.09 05/03/2024 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE INC
A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candidates for PD 1/PD L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer No dispute reported 06/30/2026 1110836936
Principal investigator 1 Daiichi Sankyo Inc. $6,800.00 04/01/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064623
Principal investigator 1 Daiichi Sankyo Inc. $7,000.00 02/23/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064621
Principal investigator 1 Daiichi Sankyo Inc. $500.00 01/26/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064617
Principal investigator 1 Daiichi Sankyo Inc. $16,350.00 01/26/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064619
Principal investigator 1 Daiichi Sankyo Inc. $15,800.00 01/22/2024 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1086064615